Abortion drug rulings spur drugmaker worries about precedent
WASHINGTON — Experts worry two recent rulings challenging the Food and Drug Administration’s regulation of a drug used in medication abortions threaten to complicate the agency’s oversight and the pipeline for future research and drug approvals.
Tribune News Service ·